Nucleai, a Chicago health-tech startup powered by AI, is hoping to get to clinical trials following a recent raise. The company recently pulled in $14 million in new funding, led by M Ventures, bringing the startup's total funding to date to $60 million. The Series B extension will allow Nucleai to deploy its AI-powered spatial [...]The post 50 Companies Igniting Chicago's Startup Scene in 2024 appeared first on Nucleai.
Nucleai is an Illinois-based AI-driven spatial platform that provides solutions such as biomarker scoring, and genomic screening for the healthcare industry.